Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Poorly Controlled Asthma During Pregnancy Remains Common in the United States.

Cohen JM, Bateman BT, Huybrechts KF, Mogun H, Yland J, Schatz M, Wurst KE, Hernandez-Diaz S.

J Allergy Clin Immunol Pract. 2019 Jun 27. pii: S2213-2198(19)30500-8. doi: 10.1016/j.jaip.2019.05.043. [Epub ahead of print]

PMID:
31257187
2.

The Impact of Technology on the Diagnosis of Congenital Malformations.

Straub L, Huybrechts KF, Bateman BT, Mogun H, Gray KJ, Holmes LB, Hernandez-Diaz S.

Am J Epidemiol. 2019 Jun 26. pii: kwz153. doi: 10.1093/aje/kwz153. [Epub ahead of print]

PMID:
31241162
3.

Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes.

Cohen JM, Huybrechts KF, Patorno E, Desai RJ, Mogun H, Bateman BT, Hernández-Díaz S.

J Clin Psychiatry. 2019 Jun 18;80(4). pii: 18m12572. doi: 10.4088/JCP.18m12572.

PMID:
31237992
4.

Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.

Huybrechts KF, Hernández-Díaz S, Straub L, Gray KJ, Zhu Y, Patorno E, Desai RJ, Mogun H, Bateman BT.

JAMA. 2018 Dec 18;320(23):2429-2437. doi: 10.1001/jama.2018.18307.

PMID:
30561479
5.

β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study.

Bateman BT, Heide-Jørgensen U, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Selmer R, Huybrechts KF, Zoega H.

Ann Intern Med. 2018 Nov 20;169(10):665-673. doi: 10.7326/M18-0338. Epub 2018 Oct 16.

PMID:
30326014
6.

Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study.

Panchaud A, Cohen JM, Patorno E, Huybrechts KF, Desai RJ, Gray KJ, Mogun H, Hernandez-Diaz S, Bateman BT.

Neurology. 2018 Aug 7;91(6):e533-e542. doi: 10.1212/WNL.0000000000005944. Epub 2018 Jul 6.

7.

Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.

Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, Glynn RJ, Cohen LS, Mogun H, Huybrechts KF.

Am J Psychiatry. 2018 Jun 1;175(6):564-574. doi: 10.1176/appi.ajp.2018.17040393. Epub 2018 May 7.

8.

Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study.

Park Y, Bateman BT, Kim DH, Hernandez-Diaz S, Patorno E, Glynn RJ, Mogun H, Huybrechts KF.

BMJ. 2018 Mar 28;360:k1218. doi: 10.1136/bmj.k1218.

9.

Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015.

Bermas BL, Kim SC, Huybrechts K, Mogun H, Hernandez-Diaz S, Bateman BT, Desai RJ.

Lupus. 2018 Jan 1:961203317749046. doi: 10.1177/0961203317749046. [Epub ahead of print]

PMID:
29301469
10.

Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study.

Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Pennell PB, Bateman BT, Patorno E.

Neurology. 2018 Jan 23;90(4):e342-e351. doi: 10.1212/WNL.0000000000004857. Epub 2017 Dec 27.

11.

Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.

Huybrechts KF, Bröms G, Christensen LB, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Karlsson P, Karlstad Ø, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Sørensen HT, Zoega H, Bateman BT.

JAMA Psychiatry. 2018 Feb 1;75(2):167-175. doi: 10.1001/jamapsychiatry.2017.3644.

12.

"Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".

Jackson JW, Fulchino L, Rogers J, Mogun H, Polinski J, Henderson DC, Schneeweiss S, Fischer MA.

Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):95-104. doi: 10.1002/pds.4354. Epub 2017 Nov 23.

PMID:
29168261
13.

Placental Complications Associated With Psychostimulant Use in Pregnancy.

Cohen JM, Hernández-Díaz S, Bateman BT, Park Y, Desai RJ, Gray KJ, Patorno E, Mogun H, Huybrechts KF.

Obstet Gynecol. 2017 Dec;130(6):1192-1201. doi: 10.1097/AOG.0000000000002362.

14.

Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease.

Desai RJ, Spoendlin J, Mogun H, Gagne JJ.

Pharmacotherapy. 2017 Oct;37(10):1322-1327. doi: 10.1002/phar.2018. Epub 2017 Sep 19.

PMID:
28833345
15.

Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.

Huybrechts KF, Bateman BT, Desai RJ, Hernandez-Diaz S, Rough K, Mogun H, Kerzner LS, Davis JM, Stover M, Bartels D, Cottral J, Patorno E.

BMJ. 2017 Aug 2;358:j3326. doi: 10.1136/bmj.j3326.

16.

Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States.

Park Y, Huybrechts KF, Cohen JM, Bateman BT, Desai RJ, Patorno E, Mogun H, Cohen LS, Hernandez-Diaz S.

Psychiatr Serv. 2017 Nov 1;68(11):1112-1119. doi: 10.1176/appi.ps.201600408. Epub 2017 Jun 15.

17.

Lithium Use in Pregnancy and the Risk of Cardiac Malformations.

Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernandez-Diaz S.

N Engl J Med. 2017 Jun 8;376(23):2245-2254. doi: 10.1056/NEJMoa1612222.

18.

Pregabalin use early in pregnancy and the risk of major congenital malformations.

Patorno E, Bateman BT, Huybrechts KF, MacDonald SC, Cohen JM, Desai RJ, Panchaud A, Mogun H, Pennell PB, Hernandez-Diaz S.

Neurology. 2017 May 23;88(21):2020-2025. doi: 10.1212/WNL.0000000000003959. Epub 2017 Apr 26.

19.

Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.

Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y, Dejene SZ, Cohen J, Mogun H, Kim SC.

BMJ. 2017 Mar 6;356:j895. doi: 10.1136/bmj.j895.

20.

Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations.

Bateman BT, Patorno E, Desai RJ, Seely EW, Mogun H, Dejene SZ, Fischer MA, Friedman AM, Hernandez-Diaz S, Huybrechts KF.

Obstet Gynecol. 2017 Jan;129(1):174-184. doi: 10.1097/AOG.0000000000001775.

21.

Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.

Bateman BT, Patorno E, Desai RJ, Seely EW, Mogun H, Maeda A, Fischer MA, Hernandez-Diaz S, Huybrechts KF.

Pediatrics. 2016 Sep;138(3). pii: e20160731. doi: 10.1542/peds.2016-0731.

22.

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.

Huybrechts KF, Hernández-Díaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, Cohen JM, Panchaud A, Cohen L, Bateman BT.

JAMA Psychiatry. 2016 Sep 1;73(9):938-46. doi: 10.1001/jamapsychiatry.2016.1520.

23.

Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture.

Kim SC, Kim DH, Mogun H, Eddings W, Polinski JM, Franklin JM, Solomon DH.

J Bone Miner Res. 2016 Aug;31(8):1536-40. doi: 10.1002/jbmr.2832. Epub 2016 Mar 31.

24.

Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions.

Desai RJ, Huybrechts KF, Bateman BT, Hernandez-Diaz S, Mogun H, Gopalakrishnan C, Patorno E, Kim SC.

Arthritis Rheumatol. 2016 May;68(5):1183-9. doi: 10.1002/art.39521.

25.

The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program.

Palmsten K, Hernández-Díaz S, Chambers CD, Mogun H, Lai S, Gilmer TP, Huybrechts KF.

Obstet Gynecol. 2015 Sep;126(3):465-73. doi: 10.1097/AOG.0000000000000982.

26.

Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures.

Bateman BT, Huybrechts KF, Maeda A, Desai R, Patorno E, Seely EW, Ecker JL, Allen-Coleman C, Mogun H, Hernandez-Diaz S, Fischer MA.

Obstet Gynecol. 2015 Aug;126(2):271-8. doi: 10.1097/AOG.0000000000000908.

27.

Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.

Swanson SA, Hernandez-Diaz S, Palmsten K, Mogun H, Olfson M, Huybrechts KF.

Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):934-42. doi: 10.1002/pds.3798. Epub 2015 Jun 4.

28.

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.

Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernandez-Diaz S.

JAMA. 2015 Jun 2;313(21):2142-51. doi: 10.1001/jama.2015.5605.

29.

Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.

Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, Kerzner LS, Bateman BT.

BMJ. 2015 May 14;350:h2102. doi: 10.1136/bmj.h2102.

30.

Statins and congenital malformations: cohort study.

Bateman BT, Hernandez-Diaz S, Fischer MA, Seely EW, Ecker JL, Franklin JM, Desai RJ, Allen-Coleman C, Mogun H, Avorn J, Huybrechts KF.

BMJ. 2015 Mar 17;350:h1035. doi: 10.1136/bmj.h1035.

31.

Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study.

Bateman BT, Huybrechts KF, Fischer MA, Seely EW, Ecker JL, Oberg AS, Franklin JM, Mogun H, Hernandez-Diaz S.

Am J Obstet Gynecol. 2015 Mar;212(3):337.e1-14. doi: 10.1016/j.ajog.2014.09.031. Epub 2014 Sep 28.

32.

Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study.

Patorno E, Neuman MD, Schneeweiss S, Mogun H, Bateman BT.

BMJ. 2014 Jun 27;348:g4022. doi: 10.1136/bmj.g4022.

33.

Antidepressant use in pregnancy and the risk of cardiac defects.

Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S.

N Engl J Med. 2014 Jun 19;370(25):2397-407. doi: 10.1056/NEJMoa1312828.

34.

Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosis.

Solomon DH, Brown EM, Chandler D, Bower A, Barron R, Mogun H, Franklin JM.

Osteoporos Int. 2014 Sep;25(9):2255-62. doi: 10.1007/s00198-014-2757-7. Epub 2014 Jun 5.

PMID:
24899104
35.

Validity of maternal and infant outcomes within nationwide Medicaid data.

Palmsten K, Huybrechts KF, Kowal MK, Mogun H, Hernández-Díaz S.

Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):646-55. doi: 10.1002/pds.3627. Epub 2014 Apr 16.

36.

Trends in antiretroviral drug use during pregnancy among HIV-infected women on medicaid: 2000-2007.

Phiri K, Fischer MA, Mogun H, Williams PL, Palmsten K, Seage GR 3rd, Hernandez-Diaz S.

AIDS Patient Care STDS. 2014 Feb;28(2):56-65. doi: 10.1089/apc.2013.0165.

37.

Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study.

Bateman BT, Hernandez-Diaz S, Huybrechts KF, Palmsten K, Mogun H, Ecker JL, Seely EW, Fischer MA.

BJOG. 2013 Dec;120(13):1668-76; dicussion 1676-7. doi: 10.1111/1471-0528.12428. Epub 2013 Sep 11.

38.

Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.

Palmsten K, Hernández-Díaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, Mogun H, Setoguchi S.

BMJ. 2013 Aug 21;347:f4877. doi: 10.1136/bmj.f4877.

39.

Antidepressant use and risk for preeclampsia.

Palmsten K, Huybrechts KF, Michels KB, Williams PL, Mogun H, Setoguchi S, Hernández-Díaz S.

Epidemiology. 2013 Sep;24(5):682-91. doi: 10.1097/EDE.0b013e31829e0aaa.

40.

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations.

Palmsten K, Huybrechts KF, Mogun H, Kowal MK, Williams PL, Michels KB, Setoguchi S, Hernández-Díaz S.

PLoS One. 2013 Jun 26;8(6):e67405. doi: 10.1371/journal.pone.0067405. Print 2013.

41.

National trends in antidepressant medication treatment among publicly insured pregnant women.

Huybrechts KF, Palmsten K, Mogun H, Kowal M, Avorn J, Setoguchi-Iwata S, Hernández-Díaz S.

Gen Hosp Psychiatry. 2013 May-Jun;35(3):265-71. doi: 10.1016/j.genhosppsych.2012.12.010. Epub 2013 Jan 30.

42.

Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population.

Bateman BT, Hernandez-Diaz S, Huybrechts KF, Palmsten K, Mogun H, Ecker JL, Fischer MA.

Hypertension. 2012 Oct;60(4):913-20. doi: 10.1161/HYPERTENSIONAHA.112.197095. Epub 2012 Sep 10.

43.

Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.

Juillerat P, Schneeweiss S, Cook EF, Ananthakrishnan AN, Mogun H, Korzenik JR.

Aliment Pharmacol Ther. 2012 Aug;36(3):239-47. doi: 10.1111/j.1365-2036.2012.05173.x. Epub 2012 Jun 5.

44.

The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults.

Patrick AR, Shrank WH, Glynn RJ, Solomon DH, Dormuth CR, Avorn J, Cadarette SM, Mogun H, Brookhart MA.

Value Health. 2011 Jun;14(4):513-20. doi: 10.1016/j.jval.2010.10.033. Epub 2011 Apr 22.

45.

Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients.

Li Q, Glynn RJ, Dreyer NA, Liu J, Mogun H, Setoguchi S.

Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):700-8. doi: 10.1002/pds.2146. Epub 2011 May 14.

PMID:
21608070
46.

Antidepressants and fracture risk in older adults: a comparative safety analysis.

Gagne JJ, Patrick AR, Mogun H, Solomon DH.

Clin Pharmacol Ther. 2011 Jun;89(6):880-7. doi: 10.1038/clpt.2011.54. Epub 2011 Apr 20.

47.

Validation of rheumatoid arthritis diagnoses in health care utilization data.

Kim SY, Servi A, Polinski JM, Mogun H, Weinblatt ME, Katz JN, Solomon DH.

Arthritis Res Ther. 2011 Feb 23;13(1):R32. doi: 10.1186/ar3260.

48.

Correlations of nursing home characteristics with prescription of osteoporosis medications.

Parikh S, Brookhart MA, Stedman M, Avorn J, Mogun H, Solomon DH.

Bone. 2011 May 1;48(5):1164-8. doi: 10.1016/j.bone.2011.02.006. Epub 2011 Feb 21.

49.

Risk of fractures in older adults using antihypertensive medications.

Solomon DH, Mogun H, Garneau K, Fischer MA.

J Bone Miner Res. 2011 Jul;26(7):1561-7. doi: 10.1002/jbmr.356.

50.

Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults.

Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Stürmer T.

Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1248-55. doi: 10.1002/pds.2031. Epub 2010 Oct 7.

Supplemental Content

Support Center